Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mind Medicine (MindMed) Inc.

5.77
+0.31005.68%
Post-market: 5.75-0.0200-0.35%19:48 EDT
Volume:1.17M
Turnover:6.66M
Market Cap:434.88M
PE:-3.74
High:5.84
Open:5.46
Low:5.45
Close:5.46
Loading ...

BRIEF-Mindmed Announces First Patient Dosed In Phase 3 Voyage Study Of Mm120 In Generalized Anxiety Disorder (Gad)

Reuters
·
16 Dec 2024

Mind Med: First patient dosed in Voyage study of LSD in treatment of GAD

TIPRANKS
·
16 Dec 2024

Mind Medicine (MindMed) Inc - Topline Data From 12-Week Double-Blind Period Expected in First Half of 2026

THOMSON REUTERS
·
16 Dec 2024

Mind Medicine (MindMed) Inc - Panorama Study to Initiate in U.S. and Europe in First Half of 2025

THOMSON REUTERS
·
16 Dec 2024

MindMed Announces First Patient Dosed in Phase 3 Voyage Study of Mm120 in Generalized Anxiety Disorder (Gad)

THOMSON REUTERS
·
16 Dec 2024

MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD)

Business Wire
·
16 Dec 2024

MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress

Business Wire
·
11 Dec 2024

Mind Medicine Gets UK's Innovation Passport Designation for Investigational Anxiety Disorder Treatment

MT Newswires Live
·
06 Dec 2024

Mind Medicine awarded innovation passport designation by UK to treat GAD

TIPRANKS
·
05 Dec 2024

Mind Medicine: Awarded Innovation Passport Designation by UK Ilap Steering Group for Mm120 Odt for Generalized Anxiety Disorder

THOMSON REUTERS
·
05 Dec 2024

MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD)

Business Wire
·
05 Dec 2024

MindMed Appoints Javier Muniz, M.d., as Vice President of Research and Development Strategy

THOMSON REUTERS
·
03 Dec 2024

MindMed Appoints Javier Muniz, M.D., as Vice President of Research and Development Strategy

Business Wire
·
03 Dec 2024

MindMed Announces New Employee Inducement Grants

Business Wire
·
02 Dec 2024

RBC Capital Remains a Buy on Mind Medicine (MNMD)

TIPRANKS
·
20 Nov 2024

MindMed Appoints New Chief to Boost Drug Approvals

TIPRANKS
·
19 Nov 2024

MindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and Quality Assurance Officer

Business Wire
·
18 Nov 2024

Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) market cap touched US$601m last week, benefiting both retail investors who own 41% as well as institutions

Simply Wall St.
·
14 Nov 2024

Mind Medicine Set to Engage at Key Investor Conferences

TIPRANKS
·
14 Nov 2024

MindMed to Participate in Upcoming Investor Conferences

Business Wire
·
13 Nov 2024